Compare Stocks

Edge Therapeutics NASDAQ:EDGE

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

Premium Income 10 Barrier ETF BATS:JULD

The Innovator Premium Income 10 Barrier ETF - July (JULD) is an exchange-traded fund that is based on the S&P 500 Price Return index. The fund seeks to provide a consistent income stream and a limited protective barrier against losses over a one-year period. The actively managed fund holds a package of S&P 500 FLEX options and US Treasurys JULD was launched on Jul 3, 2023 and is managed by Innovator.

PGIM S&P 500 Buffer 12 ETF - November BATS:NOVP

The PGIM S&P 500 Buffer 12 ETF - November (NOVP) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPDR S&P 500 ETF Trust over a specific holdings period. The actively managed fund holds options and collateral. NOVP was launched on May 21, 2024 and is issued by PGIM.

Invesco Russell 1000 Quality Factor ETF BATS:OQAL